Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
1.120
-0.010 (-0.88%)
At close: Apr 28, 2026, 4:00 PM EDT
1.105
-0.015 (-1.34%)
After-hours: Apr 28, 2026, 6:27 PM EDT
Biofrontera Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Revenue | 41.71 | 37.32 | 34.07 | 28.67 | 24.1 | Upgrade
|
| Revenue Growth (YoY) | 11.75% | 9.54% | 18.82% | 18.98% | 27.86% | Upgrade
|
| Cost of Revenue | 10.96 | 18.61 | 17.44 | 15.19 | 12.74 | Upgrade
|
| Gross Profit | 30.74 | 18.71 | 16.63 | 13.49 | 11.36 | Upgrade
|
| Selling, General & Admin | 38.37 | 33.84 | 37.9 | 35 | 25.96 | Upgrade
|
| Research & Development | 3.72 | 2.09 | 0.08 | - | - | Upgrade
|
| Operating Expenses | 42.09 | 35.92 | 37.98 | 35 | 25.96 | Upgrade
|
| Operating Income | -11.35 | -17.21 | -21.35 | -21.51 | -14.6 | Upgrade
|
| Interest Expense | -0.45 | -2.04 | -0.6 | -0.37 | -0.36 | Upgrade
|
| Interest & Investment Income | - | - | 0.13 | 0.18 | 0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | -0.11 | -0.03 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.59 | 1.84 | 3.04 | 16.36 | -12.65 | Upgrade
|
| EBT Excluding Unusual Items | -11.21 | -17.41 | -18.89 | -5.38 | -27.6 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -0.75 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0 | -0.01 | -7.42 | 1.75 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.7 | - | - | - | - | Upgrade
|
| Legal Settlements | - | - | 6.16 | -0.87 | -11.25 | Upgrade
|
| Other Unusual Items | - | -0.32 | 0.03 | 3.89 | 1.94 | Upgrade
|
| Pretax Income | -10.51 | -17.74 | -20.12 | -0.61 | -37.66 | Upgrade
|
| Income Tax Expense | 0.03 | 0.02 | 0.01 | 0.03 | 0.06 | Upgrade
|
| Net Income | -10.54 | -17.76 | -20.13 | -0.64 | -37.71 | Upgrade
|
| Net Income to Common | -10.54 | -17.76 | -20.13 | -0.64 | -37.71 | Upgrade
|
| Shares Outstanding (Basic) | 10 | 6 | 2 | 1 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 10 | 6 | 2 | 1 | 0 | Upgrade
|
| Shares Change (YoY) | 84.40% | 256.75% | 46.29% | 140.00% | - | Upgrade
|
| EPS (Basic) | -1.04 | -3.22 | -13.02 | -0.61 | -85.63 | Upgrade
|
| EPS (Diluted) | -1.04 | -3.22 | -13.02 | -0.61 | -85.63 | Upgrade
|
| Free Cash Flow | -13.36 | -10.28 | -24.9 | -16.24 | -26.73 | Upgrade
|
| Free Cash Flow Per Share | -1.31 | -1.86 | -16.10 | -15.36 | -60.68 | Upgrade
|
| Gross Margin | 73.71% | 50.14% | 48.80% | 47.04% | 47.13% | Upgrade
|
| Operating Margin | -27.21% | -46.11% | -62.67% | -75.02% | -60.59% | Upgrade
|
| Profit Margin | -25.26% | -47.58% | -59.09% | -2.23% | -156.49% | Upgrade
|
| Free Cash Flow Margin | -32.04% | -27.54% | -73.08% | -56.63% | -110.90% | Upgrade
|
| EBITDA | -11.21 | -16.79 | -20.85 | -20.99 | -14.06 | Upgrade
|
| EBITDA Margin | -26.88% | -44.98% | -61.19% | -73.21% | -58.34% | Upgrade
|
| D&A For EBITDA | 0.14 | 0.42 | 0.5 | 0.52 | 0.54 | Upgrade
|
| EBIT | -11.35 | -17.21 | -21.35 | -21.51 | -14.6 | Upgrade
|
| EBIT Margin | -27.21% | -46.11% | -62.67% | -75.02% | -60.59% | Upgrade
|
| Revenue as Reported | 41.71 | 37.32 | 34.07 | 28.67 | 24.1 | Upgrade
|
| Advertising Expenses | - | - | 0.2 | 0.1 | 0.5 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.